Can a sensory room soothe Dementia's agitation and anxiety?

NCT ID NCT07657208

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether Snoezelen multisensory therapy — a calming, personalized experience using lights, sounds, textures, and scents — can reduce agitation, depression, and anxiety in older adults with dementia. Sixty participants with mild to moderate dementia will receive either standard care or standard care plus three 30-minute Snoezelen sessions per week for 12 weeks. Researchers will measure changes in mood, behavior, heart rate, and stress hormones to see if this drug-free approach improves well-being.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Snoezelen Multisensory Therapy
What this could lead to
If effective, this drug-free therapy could offer a way to ease distressing symptoms like agitation and depression in people with dementia.
What could go wrong
This is a small, early-stage trial with only 60 participants, so results may not apply widely. The therapy may provide only temporary relief.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DEMENTIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Behavior Cognitive Dysfunction dementia Depression Psychomotor Agitation

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Center for Older Adults Lucija

    Portorož, 6320, Slovenia

More trials for these conditions

Other studies related to the condition(s) this trial covers.